Cytel and Pfizer team up for webinar on next generation feasibility, showcasing new patient recruitment and enrollment forecasting techniques featured in Cytel’s Enforesys ®.
Cytel is bringing together leaders from industry and academia, to host a full-day event on Statistical Innovations in Clinical Trials.
--Simona Skerjanec, VP Medical Science
The Medicines Company
--Steven B. Ketchum, VP Research and Development
--Joe Heyes, VP
Early Stage Biostatistics Merck
--Dr. Scott Harris, CMO
--Dr. Patrice Rioux, VP, CMO
--Sylvain Nicolas, Global Head Biostatistics Phase 1 Studies